These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6945118)

  • 1. Antagonism of drugs used in leukaemia therapy to the killing of human lymphoblastoid cells by steroid.
    Gledhill RM; Norman MR
    Br J Cancer; 1981 Sep; 44(3):467-71. PubMed ID: 6945118
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition by chemotherapeutic agents of human bone marrow progenitor cells and clonogenic cells of a lymphoblastic cell line.
    Williams CK; Ohnuma T; Holland JF
    Eur J Cancer (1965); 1981 May; 17(5):519-26. PubMed ID: 6975210
    [No Abstract]   [Full Text] [Related]  

  • 3. Synergistic killing of human leukaemic lymphoblasts by glucocorticoids and cytosine arabinoside.
    Gledhill RM; Edwards AJ; Norman MR
    Br J Cancer; 1983 May; 47(5):649-57. PubMed ID: 6573907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antiproliferative effects on HL-60 cells: deferoxamine enhances cytosine arabinoside, methotrexate, and daunorubicin cytotoxicity.
    Estrov Z; Cohen A; Gelfand EW; Freedman MH
    Am J Pediatr Hematol Oncol; 1988; 10(4):288-91. PubMed ID: 3239704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cytotoxic drugs on neutrophil phagocytosis in vitro and in patients with acute myelogenous leukaemia.
    Davies JE; Whittaker JA; Khurshid M
    Br J Haematol; 1976 Jan; 32(1):21-7. PubMed ID: 769820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal encapsulation of a synergistic molar ratio of cytarabine and daunorubicin enhances selective toxicity for acute myeloid leukemia progenitors as compared to analogous normal hematopoietic cells.
    Kim HP; Gerhard B; Harasym TO; Mayer LD; Hogge DE
    Exp Hematol; 2011 Jul; 39(7):741-50. PubMed ID: 21530609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kinetic effect of cytostatic drugs on the generation cycle of human leukaemic blast cells in vivo. A review].
    Ernst P
    Ugeskr Laeger; 1974 Mar; 136(13):695-703. PubMed ID: 4522768
    [No Abstract]   [Full Text] [Related]  

  • 8. Two dimensional view of combination chemotherapy in vitro.
    Grünwald HW; Rosner F; Hirshaut Y
    Am J Hematol; 1978; 4(1):35-46. PubMed ID: 655156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell kinetics and practical consequences for therapy of acute leukemia.
    Bleich HL; Boro ES
    N Engl J Med; 1975 Aug; 293(8):389-93. PubMed ID: 1057045
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biochemistry of antileukemic drugs].
    Bollag W
    Schweiz Med Wochenschr; 1970 Feb; 100(7):310-4. PubMed ID: 4908606
    [No Abstract]   [Full Text] [Related]  

  • 11. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fourteen relapses of acute lymphoblastic leukaemia in a child.
    Armata J; Wyszkowski J
    Haematologia (Budap); 1973; 7(3):413-7. PubMed ID: 4524438
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple basis of combination chemotherapy.
    Mihich E; Grindey GB
    Cancer; 1977 Jul; 40(1 Suppl):534-43. PubMed ID: 328136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cloretazine (VNP40101M) on acute myeloid leukaemia blast cells in vitro as a single agent and combined with cytarabine and daunorubicin.
    Morris KL; Adams JA; Liu Yin JA
    Leuk Res; 2009 Aug; 33(8):1096-9. PubMed ID: 19268363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of resistance to daunomycin (NSC-82151) in Ehrlich ascites tumor.
    Dano K
    Cancer Chemother Rep; 1971 Apr; 55(2):133-41. PubMed ID: 5118683
    [No Abstract]   [Full Text] [Related]  

  • 16. Synergistic effects of troglitazone in combination with cytotoxic agents in acute myelogenous leukaemia cells.
    Gu C; Ye T; Wells RA
    Leuk Res; 2006 Nov; 30(11):1447-51. PubMed ID: 16704876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic and cytotoxic effects of cytarabine and daunorubicin on cells in culture.
    Fried J; Perez AG; Doblin J; Clarkson BD
    Cancer Treat Rep; 1981; 65(1-2):153-6. PubMed ID: 7194735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA synthesis in leukemic cells under the action of cytotoxic agents in vitro and in vivo.
    Wilmanns W
    Natl Cancer Inst Monogr; 1971 Dec; 34():153-9. PubMed ID: 5291099
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro.
    Duncan R; Kopecková-Rejmanová P; Strohalm J; Hume I; Cable HC; Pohl J; Lloyd JB; Kopecek J
    Br J Cancer; 1987 Feb; 55(2):165-74. PubMed ID: 3468994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of adult lymphoblastic leukaemia using cyclical chemotherapy with three combinations of four drugs (COAP, POMP, TRAP schedule).
    Proctor SJ; Finney R; Walker W; Thompson RB
    Postgrad Med J; 1981 Jan; 57(663):19-22. PubMed ID: 6944694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.